CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,080,000 | -81.9% | 600,000 | -15.8% | 0.12% | -83.5% |
| Q2 2020 | $5,977,000 | +60.1% | 712,400 | 0.0% | 0.76% | +50.1% |
| Q1 2020 | $3,733,000 | +8.1% | 712,400 | +12.7% | 0.50% | +59.8% |
| Q4 2019 | $3,453,000 | +27.2% | 632,400 | +13.5% | 0.32% | +17.9% |
| Q3 2019 | $2,715,000 | -29.7% | 557,400 | 0.0% | 0.27% | -26.8% |
| Q2 2019 | $3,863,000 | -0.3% | 557,400 | 0.0% | 0.37% | -4.7% |
| Q1 2019 | $3,874,000 | – | 557,400 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $1,273,000 | 0.73% |
| ETF MANAGERS GROUP, LLC | 7,062,485 | $1,787,000 | 0.05% |
| Ikarian Capital, LLC | 862,527 | $217,000 | 0.04% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 457,209 | $115,000 | 0.02% |
| Platform Technology Partners | 33,750 | $9,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 910,006 | $230,000 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $7,683 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,029,171 | $1,016,000 | 0.00% |
| Vident Investment Advisory, LLC | 267,612 | $67,000 | 0.00% |
| Aries Wealth Management | 15,400 | $4,000 | 0.00% |